Building a national framework for the establishment of regulatory science for drug development : workshop summary /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : National Academies Press, ©2011.
Description:1 online resource (xvi, 78 pages) : color illustrations
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11258208
Hidden Bibliographic Details
Varying Form of Title:Regulatory science for drug development
Forum on Drug Discovery, Development, and Translation
Other authors / contributors:Lebovitz, Yeonwoo.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
ISBN:9780309158909
0309158907
1283019108
9781283019101
9780309158893
0309158893
Digital file characteristics:data file
Notes:Includes bibliographical references (pages 53-55).
Print version record.
Summary:"The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to make certain that regulatory decisions are based on the best scientific evidence. The IOM held a public workshop on February 26, 2010, to examine the state of regulatory science and to consider approaches for enhancing it."--Publisher's description.
Other form:Print version: Building a national framework for the establishment of regulatory science for drug development. Washington, D.C. : National Academies Press, ©2011 9780309158893